Retinoblastoma primary prevention: Difference between revisions
Mahshid |
No edit summary |
||
| Line 10: | Line 10: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Medicine]] | |||
[[Category: | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category: | [[Category:Primary care]] | ||
[[Category:Surgery]] | |||
Revision as of 17:57, 15 May 2019
|
Retinoblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Retinoblastoma primary prevention On the Web |
|
American Roentgen Ray Society Images of Retinoblastoma primary prevention |
|
Risk calculators and risk factors for Retinoblastoma primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
There are no primary preventive measures available for retinoblastoma.
Prevention of Retinoblastoma
There are no primary preventive measures available for retinoblastoma. Preimplantation genetic diagnosis has been performed, for families with a known germline mutation. In this procedure, embryos are fertilized using standard IVF techniques and are then biopsied at the eight cell stage. Only those embryos found to be free of the familial mutation in the retinoblastoma gene are implanted, resulting in a live birth of a healthy child.[1]
References
- ↑ Xu K, Rosenwaks Z, Beaverson K, Cholst I, Veeck L, Abramson DH (2004). "Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn". Am J Ophthalmol. 137 (1): 18–23. PMID 14700639.